THERAPEUTIC EFFECT OF COLLOID BISMUTH SUBCITRATE IN EXPERIMENTAL COLITIS IN THE RAT

被引:5
作者
ZAHAVI, I
BURG, Z
MARCUS, H
KARMELI, F
NUSINOVITZ, M
DINARI, G
机构
[1] CHILDRENS MED CTR ISRAEL,DIV PEDIAT GASTROENTEROL & NUTR,IL-49202 PETAH TIQWA,ISRAEL
[2] HADASSAH MED CTR,GASTROENTEROL UNIT,IL-91120 JERUSALEM,ISRAEL
关键词
EXPERIMENTAL COLITIS; COLLOID BISMUTH SUBCITRATE; DE-NOL; PROSTAGLANDIN E(2); RAT;
D O I
10.1159/000201245
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Colloid bismuth subcitrate (CBS) has a protective effect on ulcerated gastric and duodenal mucosa. To investigate its effect on large intestinal mucosal injury, we used acetic acid-induced colitis in the rat. Colitis was produced in male Wistar rats by rectal instillation of 1 mi of 10% acetic acid followed immediately by 1.5 ml of NaCl 0.9% (saline) enema. 1.5 ml of saline containing 240 mg of CBS or saline alone were then administered rectally every 24 h for 5 days. Another group of animals received CBS only. On the sixth day the distal colon was examined macroscopically and histologically using a 0 (normal) to 3 (necrosis) score. Prostaglandin E(2) (PGE(2)) was measured by RIA (ng/mg protein). CBS significantly reduced both macroscopic and microscopic scores from 2.09 to 1.25 (p < 0.02) and from 2.4 to 1.08 (p < 0.02) respectively. It also induced a significant reduction in PGE(2) from 1.6 to 0.57 (p < 0.004) in the inflamed colonic mucosa. The significant protective effect of topical CBS, which is accompanied by a reduction of PGE(2), indicates that CBS may have a role in the treatment of colitis.
引用
收藏
页码:211 / 213
页数:3
相关论文
共 23 条
  • [1] ACID, PEPSIN, AND MUCUS SECRETION IN PATIENTS WITH GASTRIC AND DUODENAL-ULCER BEFORE AND AFTER COLLOIDAL BISMUTH SUBCITRATE (DE-NOL)
    BARON, JH
    BARR, J
    BATTEN, J
    SIDEBOTHAM, R
    SPENCER, J
    [J]. GUT, 1986, 27 (05) : 486 - 490
  • [2] PREVENTION OF TRAVELERS DIARRHEA BY THE TABLET FORMULATION OF BISMUTH SUBSALICYLATE
    DUPONT, HL
    ERICSSON, CD
    JOHNSON, PC
    BITSURA, JAM
    DUPONT, MW
    DELACABADA, FJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (10): : 1347 - 1350
  • [3] ERICSSON CD, 1990, REV INFECT DIS, V12, pS16
  • [4] MECHANISM OF STEROID ACTION IN INFLAMMATION - INHIBITION OF PROSTAGLANDIN SYNTHESIS AND RELEASE
    FLOMAN, Y
    ZOR, U
    [J]. PROSTAGLANDINS, 1976, 12 (03): : 403 - 413
  • [5] GRYBOSKI JD, 1985, AM J GASTROENTEROL, V80, P871
  • [6] HALL DWR, 1987, ARCH INT PHARMACOD T, V286, P308
  • [7] HALL DWR, 1987, INT J TISSUE REACT, V9, P427
  • [8] HEALING AND RECURRENCE OF DUODENAL-ULCER AFTER TREATMENT WITH TRIPOTASSIUM DICITRATO BISMUTHATE (TDB) TABLETS OR CIMETIDINE
    HAMILTON, I
    OCONNOR, HJ
    WOOD, NC
    BRADBURY, I
    AXON, ATR
    [J]. GUT, 1986, 27 (01) : 106 - 110
  • [9] CYTOPROTECTIVE AND ULCER HEALING PROPERTIES OF PROSTAGLANDIN-E2, COLLOIDAL BISMUTH AND SUCRALFATE IN RATS
    KONTUREK, SJ
    STACHURA, J
    RADECKI, T
    DROZDOWICZ, D
    BRZOZOWSKI, T
    [J]. DIGESTION, 1987, 38 (02) : 103 - 113
  • [10] KOO J, 1982, GASTROENTEROLOGY, V82, P864